Guhan Pharmaceutical Group Co., Ltd. (SHE:000590)

SHE:000590 Revenue

Guhan Pharmaceutical Group had revenue of 85.93M CNY in the quarter ending September 30, 2026, with 4.31% growth. This brings the company's total for the last twelve months to 332.96M, down -5.35% year-over-year. In the year 2025, Guhan Pharmaceutical Group had annual revenue of 337.67M, down -1.61%. That makes Guhan Pharmaceutical Group the 28,025th largest company in the world by revenue and 4,807th in China.

• Revenue (ttm): 332.96M
• Revenue Growth: -5.35%
• P/S Ratio: 5.61
• Revenue / Employee: 312.93K
• Employees: 1,064
• Market Cap: 1.87B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Pharmaceutical and Health Product Manufacturing and Sales Business 523.14M 96.1%
• Other Operations 17.63M 3.2%
• Active Pharmaceutical Ingredient (API) Manufacturing and Sales Business 3.73M 0.7%

Fiscal year ended Dec 31, 2025 See the full SHE:000590 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	337.67M	-5.53M	-1.61%
Dec 31, 2024	343.21M	-61.44M	-15.18%
Dec 31, 2023	404.65M	54.12M	15.44%
Jan 1, 2023	350.53M	49.75M	16.54%
Jan 1, 2022	300.77M	25.68M	9.34%

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 11, 2026

Data Sources Report a data error